Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Point-of-care vs Commercial CAR T-cells in R/R DLBCL
NCT05641428Phase 2Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Oct 2022
- Primary completion
- Jun 2027
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of ARI-0001 in diffuse large B-cell lymphoma (DLBCL), sponsored by University Medical Center Groningen. Started Oct 2022; status: active, not recruiting.
02
Drugs
ARI-0001
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT05641428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05641428.